All Relations between Alzheimer Disease and microtubule-associated protein tau

Publication Sentence Publish Date Extraction Date Species
Ruifeng Zhang, Miao Zeng, Xiaolu Zhang, Yujia Zheng, Nuan Lv, Luming Wang, Jiali Gan, Yawen Li, Xijuan Jiang, Lin Yan. Therapeutic Candidates for Alzheimer's Disease: Saponins. International journal of molecular sciences. vol 24. issue 13. 2023-07-14. PMID:37445682. these studies suggest that saponins have the potential to ameliorate alzheimer's disease by reducing amyloid beta peptide deposition, inhibiting tau phosphorylation, modulating oxidative stress, reducing inflammation, and antiapoptosis. 2023-07-14 2023-08-14 Not clear
Constantin Kondak, Michael Leith, Thomas C Baddeley, Renato X Santos, Charles R Harrington, Claude M Wischik, Gernot Riedel, Jochen Klei. Mitochondrial Effects of Hydromethylthionine, Rivastigmine and Memantine in Tau-Transgenic Mice. International journal of molecular sciences. vol 24. issue 13. 2023-07-14. PMID:37445987. tau protein aggregations are important contributors to the etiology of alzheimer's disease (ad). 2023-07-14 2023-08-14 mouse
Amina U Syed, Christopher Liang, Krystal K Patel, Rommani Mondal, Vallabhi M Kamalia, Taylor R Moran, Shamiha T Ahmed, Jogeshwar Mukherje. Comparison of Monoamine Oxidase-A, Aβ Plaques, Tau, and Translocator Protein Levels in Postmortem Human Alzheimer's Disease Brain. International journal of molecular sciences. vol 24. issue 13. 2023-07-14. PMID:37445985. comparison of monoamine oxidase-a, aβ plaques, tau, and translocator protein levels in postmortem human alzheimer's disease brain. 2023-07-14 2023-08-14 human
Qian Zhang, Yaping Ya. The role of natural flavonoids on neuroinflammation as a therapeutic target for Alzheimer's disease: a narrative review. Neural regeneration research. vol 18. issue 12. 2023-07-14. PMID:37449593. although the pathological mechanisms underlying alzheimer's disease are complex and remain unclear, previous research has identified two widely accepted pathological characteristics: extracellular neuritic plaques containing amyloid beta peptide, and intracellular neurofibrillary tangles containing tau. 2023-07-14 2023-08-14 Not clear
Yijun Chen, Yang Y. Tau and neuroinflammation in Alzheimer's disease: interplay mechanisms and clinical translation. Journal of neuroinflammation. vol 20. issue 1. 2023-07-14. PMID:37452321. tau and neuroinflammation in alzheimer's disease: interplay mechanisms and clinical translation. 2023-07-14 2023-08-14 Not clear
Xi Xiong, Haijun He, Qianqian Ye, Shuangjie Qian, Shuoting Zhou, Feifei Feng, Evandro F Fang, Chenglong Xi. Alzheimer's disease diagnostic accuracy by fluid and neuroimaging ATN framework. CNS neuroscience & therapeutics. 2023-07-13. PMID:37438991. the atn's different modalities (fluids and neuroimaging) for each of the aβ (a), tau (t), and neurodegeneration (n) elements are used for the biological diagnosis of alzheimer's disease (ad). 2023-07-13 2023-08-14 Not clear
Kanta Horie, Gemma Salvadó, Nicolas R Barthélemy, Shorena Janelidze, Yan Li, Yingxin He, Benjamin Saef, Charles D Chen, Hong Jiang, Olof Strandberg, Alexa Pichet Binette, Sebastian Palmqvist, Chihiro Sato, Pallavi Sachdev, Akihiko Koyama, Brian A Gordon, Tammie L S Benzinger, David M Holtzman, John C Morris, Niklas Mattsson-Carlgren, Erik Stomrud, Rik Ossenkoppele, Suzanne E Schindler, Oskar Hansson, Randall J Batema. CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's disease. Nature medicine. 2023-07-13. PMID:37443334. csf mtbr-tau243 is a specific biomarker of tau tangle pathology in alzheimer's disease. 2023-07-13 2023-08-14 Not clear
Kanta Horie, Gemma Salvadó, Nicolas R Barthélemy, Shorena Janelidze, Yan Li, Yingxin He, Benjamin Saef, Charles D Chen, Hong Jiang, Olof Strandberg, Alexa Pichet Binette, Sebastian Palmqvist, Chihiro Sato, Pallavi Sachdev, Akihiko Koyama, Brian A Gordon, Tammie L S Benzinger, David M Holtzman, John C Morris, Niklas Mattsson-Carlgren, Erik Stomrud, Rik Ossenkoppele, Suzanne E Schindler, Oskar Hansson, Randall J Batema. CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's disease. Nature medicine. 2023-07-13. PMID:37443334. aggregated insoluble tau is one of two defining features of alzheimer's disease. 2023-07-13 2023-08-14 Not clear
Kanta Horie, Gemma Salvadó, Nicolas R Barthélemy, Shorena Janelidze, Yan Li, Yingxin He, Benjamin Saef, Charles D Chen, Hong Jiang, Olof Strandberg, Alexa Pichet Binette, Sebastian Palmqvist, Chihiro Sato, Pallavi Sachdev, Akihiko Koyama, Brian A Gordon, Tammie L S Benzinger, David M Holtzman, John C Morris, Niklas Mattsson-Carlgren, Erik Stomrud, Rik Ossenkoppele, Suzanne E Schindler, Oskar Hansson, Randall J Batema. CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's disease. Nature medicine. 2023-07-13. PMID:37443334. we show that the microtubule-binding region (mtbr) of tau containing the residue 243 (mtbr-tau243) is a new cerebrospinal fluid (csf) biomarker specific for insoluble tau aggregates and compared it to multiple other phosphorylated tau measures (p-tau181, p-tau205, p-tau217 and p-tau231) in two independent cohorts (biofinder-2, n = 448; and knight alzheimer disease research center, n = 219). 2023-07-13 2023-08-14 Not clear
Prapti H Mody, Kelsey N Marvin, DiAnna L Hynds, Laura K Hanso. Cytomegalovirus infection induces Alzheimer's disease-associated alterations in tau. Journal of neurovirology. 2023-07-12. PMID:37436577. cytomegalovirus infection induces alzheimer's disease-associated alterations in tau. 2023-07-12 2023-08-14 mouse
Prapti H Mody, Kelsey N Marvin, DiAnna L Hynds, Laura K Hanso. Cytomegalovirus infection induces Alzheimer's disease-associated alterations in tau. Journal of neurovirology. 2023-07-12. PMID:37436577. alzheimer's disease (ad) manifests with loss of neurons correlated with intercellular deposition of amyloid (amyloid plaques) and intracellular neurofibrillary tangles of hyperphosphorylated tau. 2023-07-12 2023-08-14 mouse
Helena Østergaard Rasmussen, Janni Nielsen, Angela de Poli, Daniel Otzen, Jan Skov Pederse. Tau Fibrillation Induced by Heparin or a Lysophospholipid Show Different Initial Oligomer Formation. Journal of molecular biology. 2023-07-12. PMID:37437877. the protein tau is involved in several neurogenerative diseases such as alzheimer's disease, where tau content and fibrillation have been linked to disease progression. 2023-07-12 2023-08-14 Not clear
Leon M Aksman, Neil P Oxtoby, Marzia A Scelsi, Peter A Wijeratne, Alexandra L Young, Isadora Lopes Alves, Lyduine E Collij, Jacob W Vogel, Frederik Barkhof, Daniel C Alexander, Andre Altman. A data-driven study of Alzheimer's disease related amyloid and tau pathology progression. Brain : a journal of neurology. 2023-07-11. PMID:37433038. a data-driven study of alzheimer's disease related amyloid and tau pathology progression. 2023-07-11 2023-08-14 Not clear
Leon M Aksman, Neil P Oxtoby, Marzia A Scelsi, Peter A Wijeratne, Alexandra L Young, Isadora Lopes Alves, Lyduine E Collij, Jacob W Vogel, Frederik Barkhof, Daniel C Alexander, Andre Altman. A data-driven study of Alzheimer's disease related amyloid and tau pathology progression. Brain : a journal of neurology. 2023-07-11. PMID:37433038. amyloid-beta is thought to facilitate the spread of tau throughout the neocortex in alzheimer's disease, though how this occurs is not well understood. 2023-07-11 2023-08-14 Not clear
Leon M Aksman, Neil P Oxtoby, Marzia A Scelsi, Peter A Wijeratne, Alexandra L Young, Isadora Lopes Alves, Lyduine E Collij, Jacob W Vogel, Frederik Barkhof, Daniel C Alexander, Andre Altman. A data-driven study of Alzheimer's disease related amyloid and tau pathology progression. Brain : a journal of neurology. 2023-07-11. PMID:37433038. the rate of longitudinal amyloid-beta and tau accumulation (both measured via pet) within this group did not differ from normal aging, supporting the distinction of primary age-related tauopathy from alzheimer's disease. 2023-07-11 2023-08-14 Not clear
Danko Jeremic, Juan D Navarro-López, Lydia Jiménez-Día. Efficacy and Safety of Anti-Amyloid-β Monoclonal Antibodies in Current Alzheimer's Disease Phase III Clinical Trials: A Systematic Review and Interactive Web App-based Meta-Analysis. Ageing research reviews. 2023-07-09. PMID:37423541. secondary and tertiary outcomes included biomarkers of aβ and tau pathology, adverse events, and performance on alzheimer's disease cooperative study - activities of daily living scale. 2023-07-09 2023-08-14 Not clear
Karthivashan Govindarajan, Satyabrata Ka. Detection of β-amyloid aggregates/plaques in 5xFAD mice by labelled native PLGA nanoparticles: implication in the diagnosis of alzheimer's disease. Journal of nanobiotechnology. vol 21. issue 1. 2023-07-09. PMID:37424018. evidence suggests that increased level/aggregation of β-amyloid (aβ) peptide, together with enhanced phosphorylation/aggregation of tau protein, play a critical role in the development of alzheimer's disease (ad), the leading cause of dementia in the elderly. 2023-07-09 2023-08-14 mouse
Shudan Gao, Yun Wang, Tao Ma, Junying Zhan. The Late Stage of Abnormal Aging: Dementia. Advances in experimental medicine and biology. vol 1419. 2023-07-07. PMID:37418213. currently, many related mechanisms of the pathogenesis of alzheimer's disease have been proposed, such as beta-amyloid (a) theory, tau protein theory, and nerve and blood vessel theory. 2023-07-07 2023-08-14 Not clear
Lu Wang, Yingjuan Wei, Zhenzhou Sun, Lin-Hua Jiang, Yaling Yin, Panpan Zheng, Yun Fu, Hongwei Wang, Changzheng Li, Jian-Zhi Wan. DpdtpA, A Multi-Metal Ion Chelator, Attenuates Tau Phosphorylation and Microglial Inflammatory Response via Regulating the PI3K/AKT/GSK-3β Signal Pathways. Neuroscience. 2023-07-07. PMID:37419407. tau protein hyperphosphorylation and formation of intracellular neurofibrillary tangles (nfts) are one of the histopathological hallmarks of alzheimer's disease (ad) and positively correlated with the severity of ad symptoms. 2023-07-07 2023-08-14 human
Shunsuke Koga, Aya Murakami, Alexandra I Soto-Beasley, Ronald L Walton, Matthew C Baker, Monica Castanedes-Casey, Keith A Josephs, Owen A Ross, Dennis W Dickso. Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies. Acta neuropathologica communications. vol 11. issue 1. 2023-07-06. PMID:37415197. her amnestic symptoms that were suggestive of alzheimer's type dementia are best explained by diffuse agd and medial temporal tdp-43 proteinopathy, and her motor symptoms were likely explained by neuronal loss and gliosis due to tau pathology in the substantia nigra. 2023-07-06 2023-08-14 Not clear